Organon & Co. (OGN)
13.74
-0.03
(-0.22%)
USD |
NYSE |
Oct 14, 16:00
13.74
0.00 (0.00%)
Pre-Market: 20:00
Organon Total Long Term Debt (Quarterly) : 8.553B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.553B |
| March 31, 2026 | 8.569B |
| December 31, 2025 | 8.76B |
| September 30, 2025 | 8.828B |
| June 30, 2025 | 8.896B |
| March 31, 2025 | 8.956B |
| December 31, 2024 | 8.992B |
| September 30, 2024 | 8.749B |
| June 30, 2024 | 8.656B |
| March 31, 2024 | 8.714B |
| December 31, 2023 | 8.885B |
| September 30, 2023 | 8.654B |
| June 30, 2023 | 8.73B |
| Date | Value |
|---|---|
| March 31, 2023 | 8.711B |
| December 31, 2022 | 9.063B |
| September 30, 2022 | 8.699B |
| June 30, 2022 | 8.893B |
| March 31, 2022 | 9.094B |
| December 31, 2021 | 9.318B |
| September 30, 2021 | 9.519B |
| June 30, 2021 | 9.575B |
| March 31, 2021 | 966.00M |
| December 31, 2020 | 23.00M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.08B |
| Viatris, Inc. | 13.51B |
| Pfizer Inc. | 63.10B |
| Pacira Biosciences, Inc. | 401.82M |
| Bristol Myers Squibb Co. | 44.59B |